Latest Drug Approvals news
FDA Approves Zilbrysq for Generalized Myasthenia Gravis
posted October 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
posted January 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New Two-Drug Combo Medicine for Asthma
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Second Drug for Alzheimer Disease, Despite Safety Concerns
posted January 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Exercise Link to Dementia Varies by Physical Activity Domain 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
